Search
The FDA Issues a Letter To Curaleaf Warning it Violated the Food, Drug and Cosmetic Act

The FDA Issues a Letter To Curaleaf Warning it Violated the Food, Drug and Cosmetic Act

Author

CannaNews

Published on August 02, 2019

America’s booming CBD market received a cold splash of reality this week when the US Food and Drug Administration issued a letter to Curaleaf, a major US cannabis and CBD brand, warning that some of its product marketing violates the Federal Food, Drug, and Cosmetic Act.



Arizona Attorney Gene

Show More
Category : News

3 Comments

cmntImg
cmntImg
davonraymond 2 weeks ago
Very interesting! I appreciate this content on theweedtube!
cmntImg
Durban_Pete 1 week ago
cmntImg
Tesa.ma 1 day ago
aren't they always claiming violations.... yet allow most of the terrible harmful American products to continue to thrive.... new subscriber here, great content! hope we can support each other
Auto Play